CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma

In recent years, several immune checkpoint inhibitors targeting programmed death-ligand 1 (PD-L1) or PD-1 have been developed for cancer therapy. The genetic background of tumors and factors that influence PD-L1 expression in tumor tissues are not yet elucidated in cutaneous squamous cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Haruto, Kondo, Yoshihiko, Kusaba, Takahiro, Kawamura, Kazuhiro, Oyama, Yuzo, Daa, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925078/
https://www.ncbi.nlm.nih.gov/pubmed/36780540
http://dx.doi.org/10.1371/journal.pone.0281647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925078/
https://www.ncbi.nlm.nih.gov/pubmed/36780540
http://dx.doi.org/10.1371/journal.pone.0281647

Ejemplares similares